Peritoneal Carcinomatosis — Trials

Peritoneal Carcinomatosis — Trials · CancerIndex

Clinical trials

Registered studies

150 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 42
Recruiting: 28
Ph III recruiting: 2
Growth YoY: —
Industry share: 2%
Top sponsor: University of California, Irvine
Termination share: 26.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (18)

clinicaltrialsPublishedShowing 1–11 of 11 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04107077	Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer	recruiting	Phase 2	21	University of ChicagoOTHER	1	Sep 8, 2026	clinicaltrials
NCT07001748	Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity(STOPGAP II)	recruiting	Phase 2 / Phase 3	148	ECOG-ACRIN Cancer Research GroupNETWORK